Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Malignant Hematologic Neoplasm
- Sponsor
- Aalborg University Hospital
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Health-Related Quality of Life (HRQoL) - General
- Last Updated
- 8 years ago
Overview
Brief Summary
The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.
Investigators
Mia Sommer
Clinical Research Nurse, ph.d. student
Aalborg University Hospital
Eligibility Criteria
Inclusion Criteria
- •patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
- •patients followed before or after
- •line treatment
- •patients in stable phase \> 6 months after
- •line treatment
- •the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment
Exclusion Criteria
- •Health conditions which demands close medical monitoring
- •conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
- •lack of capability to fill out electronic questionnaires
- •poor self-care and/or compliance
Outcomes
Primary Outcomes
Health-Related Quality of Life (HRQoL) - General
Time Frame: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public.
Health-Related Quality of Life (HRQoL) - Disease specific
Time Frame: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer
Secondary Outcomes
- Symptoms of hematological disease(Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months)
- Symptoms of depression and anxiety(Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months)